OBJECTIVE: The objective of this study was to understand the biological pathways involved in twin-twin transfusion syndrome (TTTS) by performing global gene expression analysis of amniotic fluid (AF) cell-free RNA. METHODS: A prospective whole transcriptome microarray study analyzing cell-free RNA in AF from TTTS recipient twins and singleton controls was carried out. Significantly differentially regulated genes in TTTS cases (N = 8) versus matched controls (N = 8) were identified and pathways analyses performed. Significant gene expression differences between stage II TTTS recipients (N = 5) and stage III TTTS recipients with abnormal Doppler measurements (N = 5) were also analyzed. RESULTS: Analysis of paired data from TTTS cases and controls revealed differential expression of 801 genes, which were significantly enriched for neurological disease and cardiovascular system pathways. We also identified cardiovascular genes and pathways associated with the presence of critically abnormal Doppler measurements in stage III TTTS recipients. CONCLUSIONS: This study provides the first transcriptome-wide data on the impact of TTTS on fetal development. Our results show that gene expression involving neurological and cardiovascular pathways are altered in recipient fetuses prior to surgical treatment. This has relevance for the origins of long-term complications seen in survivors and for the development of future fetal biomarkers.
OBJECTIVE: The objective of this study was to understand the biological pathways involved in twin-twin transfusion syndrome (TTTS) by performing global gene expression analysis of amniotic fluid (AF) cell-free RNA. METHODS: A prospective whole transcriptome microarray study analyzing cell-free RNA in AF from TTTS recipient twins and singleton controls was carried out. Significantly differentially regulated genes in TTTS cases (N = 8) versus matched controls (N = 8) were identified and pathways analyses performed. Significant gene expression differences between stage II TTTS recipients (N = 5) and stage III TTTS recipients with abnormal Doppler measurements (N = 5) were also analyzed. RESULTS: Analysis of paired data from TTTS cases and controls revealed differential expression of 801 genes, which were significantly enriched for neurological disease and cardiovascular system pathways. We also identified cardiovascular genes and pathways associated with the presence of critically abnormal Doppler measurements in stage III TTTS recipients. CONCLUSIONS: This study provides the first transcriptome-wide data on the impact of TTTS on fetal development. Our results show that gene expression involving neurological and cardiovascular pathways are altered in recipient fetuses prior to surgical treatment. This has relevance for the origins of long-term complications seen in survivors and for the development of future fetal biomarkers.
Authors: L Tessarollo; P Tsoulfas; M J Donovan; M E Palko; J Blair-Flynn; B L Hempstead; L F Parada Journal: Proc Natl Acad Sci U S A Date: 1997-12-23 Impact factor: 11.205
Authors: Keith Noto; Saeed Majidi; Andrea G Edlow; Heather C Wick; Diana W Bianchi; Donna K Slonim Journal: J Comput Biol Date: 2015-02-04 Impact factor: 1.479
Authors: Tomo Tarui; Aimee Kim; Alan Flake; Lauren McClain; John D Stratigis; Inbar Fried; Rebecca Newman; Donna K Slonim; Diana W Bianchi Journal: Am J Obstet Gynecol Date: 2017-07-20 Impact factor: 10.693
Authors: Andrea G Edlow; Faycal Guedj; Jeroen L A Pennings; Deanna Sverdlov; Caterina Neri; Diana W Bianchi Journal: Am J Obstet Gynecol Date: 2016-03-03 Impact factor: 8.661
Authors: Emily C Willner; Henry L Galan; Bettina F Cuneo; Hilary A Hoffman; Bonnie Neltner; Eleanor L Schuchardt; Anis Karimpour-Fard; Shelley D Miyamoto; Carmen C Sucharov Journal: Am J Obstet Gynecol Date: 2021-06-19 Impact factor: 10.693